Q9NZD8 (SPG21_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
January 25, 2012.
Version 88.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Maspardin Alternative name(s): Acid cluster protein 33 Spastic paraplegia 21 autosomal recessive Mast syndrome protein Spastic paraplegia 21 protein | ||||||
| Gene names |
| ||||||
| Organism | Homo sapiens (Human) | ||||||
| Taxonomic identifier | 9606 [NCBI] | ||||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 308 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | May play a role as a negative regulatory factor in CD4-dependent T-cell activation. Ref.1 |
| Subunit structure | |
| Subcellular location | Cytoplasm › cytosol. Membrane; Peripheral membrane protein. Endosome membrane; Peripheral membrane protein. Golgi apparatus › trans-Golgi network membrane; Peripheral membrane protein. Note: Partially localized in the cytosol but also accumulated on an intracellular vesicular compartment. Colocalizes with CD4 on endosomal/trans-Golgi network. Ref.1 |
| Tissue specificity | Expressed in all tissues tested, including heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. Expressed in JCaM1.6, HUT 78 and HeLa cell lines (at protein level). Ref.1 |
| Involvement in disease | Defects in SPG21 are the cause of spastic paraplegia autosomal recessive type 21 (SPG21) [MIM:248900]; also known as Mast syndrome. Spastic paraplegia is a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. SPG21 is associated with dementia and other central nervous system abnormalities. Subtle childhood abnormalities may be present, but the main features develop in early adulthood. The disease is slowly progressive, and cerebellar and extrapyramidal signs are also found in patients with advanced disease. Patients have a thin corpus callosum and white-matter abnormalities. Ref.8 |
| Sequence similarities | Belongs to the AB hydrolase superfamily. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Cytoplasm Endosome Golgi apparatus Membrane |
| Coding sequence diversity | Alternative splicing |
| Disease | Hereditary spastic paraplegia Neurodegeneration |
| PTM | Phosphoprotein |
| Technical term | Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Biological process | antigen receptor-mediated signaling pathway Inferred by curator Ref.1. Source: UniProtKB cell deathInferred from electronic annotation. Source: UniProtKB-KW |
| Cellular component | cytosol Inferred from direct assay Ref.1. Source: UniProtKB endosome membraneInferred from electronic annotation. Source: UniProtKB-SubCell nucleusInferred from direct assay. Source: HPA trans-Golgi network transport vesicleInferred from direct assay Ref.1. Source: UniProtKB |
| Molecular function | CD4 receptor binding Inferred from physical interaction Ref.1. Source: UniProtKB |
| Complete GO annotation... | |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q9NZD8-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q9NZD8-2) The sequence of this isoform differs from the canonical sequence as follows: 76-102: Missing. | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 308 | 308 | Maspardin | PRO_0000227980 | |||||
Amino acid modifications | |||||||||
| Modified residue | 304 | 1 | Phosphoserine Ref.9 | ||||||
Natural variations | |||||||||
| Alternative sequence | 76 – 102 | 27 | Missing in isoform 2. | VSP_041512 | |||||
Experimental info | |||||||||
| Mutagenesis | 109 | 1 | S → A: Abolishes interaction with CD4. Ref.1 | ||||||
| Sequence conflict | 40 | 1 | R → Q in BAG62906. Ref.4 | ||||||
| Sequence conflict | 58 | 1 | V → A in BAG62906. Ref.4 | ||||||
| Sequence conflict | 210 | 1 | E → V in BAD18813. Ref.4 | ||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Cloning of ACP33 as a novel intracellular ligand of CD4." Zeitlmann L., Sirim P., Kremmer E., Kolanus W. J. Biol. Chem. 276:9123-9132(2001) [PubMed: 11113139] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY, SUBCELLULAR LOCATION, INTERACTION WITH CD4, MUTAGENESIS OF SER-109. |
| [2] | "A novel gene expressed in human bone marrow." Zhao M., Song H., Li N., Peng Y., Han Z., Chen Z. Submitted (NOV-1999) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Bone marrow. |
| [3] | "A novel gene expressed in human liver non-tumor tissues." Li Y., Wu T., Xu S., Ren S., Chen Z., Han Z. Submitted (DEC-1999) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Liver. |
| [4] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2). Tissue: Synovium. |
| [5] | "Analysis of the DNA sequence and duplication history of human chromosome 15." Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K., Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N., Abouelleil A. Nusbaum C.Nature 440:671-675(2006) [PubMed: 16572171] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [7] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Eye. |
| [8] | "Maspardin is mutated in Mast syndrome, a complicated form of hereditary spastic paraplegia associated with dementia." Simpson M.A., Cross H., Proukakis C., Pryde A., Hershberger R., Chatonnet A., Patton M.A., Crosby A.H. Am. J. Hum. Genet. 73:1147-1156(2003) [PubMed: 14564668] [Abstract] Cited for: INVOLVEMENT IN SPG21. |
| [9] | "Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach." Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S. Anal. Chem. 81:4493-4501(2009) [PubMed: 19413330] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-304, MASS SPECTROMETRY. Tissue: Embryonic kidney. |
| [10] | "Interaction of the SPG21 protein ACP33/maspardin with the aldehyde dehydrogenase ALDH16A1." Hanna M.C., Blackstone C. Neurogenetics 10:217-228(2009) [PubMed: 19184135] [Abstract] Cited for: INTERACTION WITH ALDH16A1. |
| [11] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed: 21269460] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AF208861 mRNA. Translation: AAF64275.1. AF212231 mRNA. Translation: AAK14917.1. AK172849 mRNA. Translation: BAD18813.1. AK301362 mRNA. Translation: BAG62906.1. AC069368 Genomic DNA. No translation available. AC103691 Genomic DNA. No translation available. CH471082 Genomic DNA. Translation: EAW77704.1. BC000244 mRNA. Translation: AAH00244.1. |
| IPI | IPI00010248. IPI00895915. |
| RefSeq | NP_001121361.1. NM_001127889.1. NP_001121362.1. NM_001127890.1. NP_057714.1. NM_016630.3. |
| UniGene | Hs.242458. |
3D structure databases | |
| ProteinModelPortal | Q9NZD8. |
| SMR | Q9NZD8. Positions 37-139. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | Q9NZD8. 11 interactions. |
| MINT | MINT-1443026. |
| STRING | Q9NZD8. |
PTM databases | |
| PhosphoSite | Q9NZD8. |
Polymorphism databases | |
| DMDM | 74734726. |
Proteomic databases | |
| PRIDE | Q9NZD8. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000204566; ENSP00000204566; ENSG00000090487. ENST00000433215; ENSP00000404111; ENSG00000090487. |
| GeneID | 51324. |
| KEGG | hsa:51324. |
| UCSC | uc002aod.1. human. |
Organism-specific databases | |
| CTD | 51324. |
| GeneCards | GC15M065255. |
| H-InvDB | HIX0012344. |
| HGNC | HGNC:20373. SPG21. |
| HPA | HPA040436. |
| MIM | 248900. phenotype. 608181. gene. |
| neXtProt | NX_Q9NZD8. |
| Orphanet | 101001. Autosomal recessive spastic paraplegia type 21. |
| PharmGKB | PA134921126. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | prNOG13789. |
| GeneTree | ENSGT00390000007857. |
| HOGENOM | HBG446721. |
| HOVERGEN | HBG080704. |
| InParanoid | Q9NZD8. |
| OMA | EVNLYIQ. |
| OrthoDB | EOG4640CF. |
| PhylomeDB | Q9NZD8. |
Gene expression databases | |
| ArrayExpress | Q9NZD8. |
| Bgee | Q9NZD8. |
| CleanEx | HS_SPG21. |
| Genevestigator | Q9NZD8. |
| GermOnline | ENSG00000090487. Homo sapiens. |
Family and domain databases | |
| ProtoNet | Search... |
Other | |
| NextBio | 54722. |
| SOURCE | Search... |
Entry information
| Entry name | SPG21_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9NZD8 Secondary accession number(s): B4DW44, Q6ZMB6 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 15 Human chromosome 15: entries, gene names and cross-references to MIM |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with